The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Kropz gets more cash; Audioboom releases new podcasts

Thu, 01st Sep 2022 21:55

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Open Orphan PLC - London-based pharmaceutical services - Its clinical laboratories in Queen Mary's Bioenterprise Centre and Plumbers Row wins accreditation by the College of American Pathologists. "The company sought the accreditation as part of its ongoing commitment to maintaining best in class quality systems," it explains.

----------

Audioboom Group PLC - London-based podcast producer - Expands its podcast network with the launch of three new shows from Audioboom Studios, the company's production arm. "Audioboom's continued investment into content development will further grow the company's intellectual property, deliver increased gross margins to the business, expand audience reach, and develop premium advertising inventory," it says. Launches 'Glittering A Turd' from Kris Hallenga, 'Killers, Cults and Queens' from Cheryl Hole and Nikki Druce, and 'Superpower State of Mind' from Malin Andersson.

----------

Sopheon PLC - Minnesota, US-based enterprise software provider - Updates management product Accolade. "Using Accolade, Sopheon's long-standing blue-chip customers across a diverse range of industries have experienced superior strategy-to-execution performance, reduced time-to-market, improved efficiency, and greater product success rate," it explains.

----------

Cloudbreak Discovery PLC - Vancouver, Canada-based natural resource project generator - Draws down GBP180,000 of the GBP10 million equity drawdown agreement with Crescita Capital LLC, which was originally entered into in February 2021. Shares issued at 1.5 pence each, seeing 12 million new shares issued. "The capital drawn down will be used to advance the company's acquisitions of energy royalties, lithium assets and bauxite projects globally," it explains.

----------

Power Metal Resources PLC - metals exploration company focused on North America, Africa and Australia - Wholly owned Australian subsidiary Power Metal Resources Australia sees confirmation of grant of exploration licence application 2021-000163, covering 999 square kilometres of ground in the Anna Creek area of South Australia. Exploration licence will last for 6 years, ending August 2028, and subject to minimum spend of AUD100,000, about GBP59,000. Chief Executive Paul Johnson says: "There is more work to do, clearly, and we are early stage here, however all projects of substance start early stage and the Wilan Project is off to a great start."

----------

Kropz PLC - African phosphate developer - Draws down ZAR47 million from recent bridge loan facility of ZAR121.5 million with major shareholder, the ARC Fund, to meet immediate cash requirements due to further delays in the ramp up of operations at Kropz Elandsfontein Ltd. "Progress continues to be made, however, in the ramp up," it adds. "Kropz and ARC Fund are currently working on a comprehensive funding structure to finance any further funding requirements in Kropz."

----------

Hummingbird Resources PLC - gold production, development and exploration focused on West Africa - Says development and construction of its second gold mine, Kouroussa, is now over 50% completed and remains on time and budget to achieve first gold pour by the end of the second quarter of 2023, which will more than double Hummingbird's gold production profile. Notes final assay results confirmed, with results showing 9.0 metres at 32.60 grammes per tonne gold from 116 metres.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
14 Dec 2020 11:38

Open Orphan upbeat on progress with nasal Covid-19 vaccine

(Sharecast News) - Specialist pharmaceuticals contract research organisation Open Orphan announced on Monday that the first in-human study of the Codagenix intranasal SARS-CoV-2 vaccine candidate for Covid-19 had gained approval from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).

Read more
24 Nov 2020 16:27

UK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head Exits

UK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head Exits

Read more
19 Nov 2020 21:18

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

Read more
5 Nov 2020 16:32

IN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza Study

IN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza Study

Read more
30 Oct 2020 11:30

Open Orphan secures new two-year contract with German client

(Sharecast News) - Pharmaceutical services company Open Orphan announced a new two-year contract with an unnamed tier 1 Germany-based pharmaceutical company on Friday.

Read more
30 Oct 2020 11:07

Open Orphan Inks Two-Year Contract With Tier 1 German Pharma Company

Open Orphan Inks Two-Year Contract With Tier 1 German Pharma Company

Read more
20 Oct 2020 15:59

IN BRIEF: Open Orphan To Develop Covid Study Model For UK Government

IN BRIEF: Open Orphan To Develop Covid Study Model For UK Government

Read more
20 Oct 2020 09:49

Open Orphan to assist UK govt in Covid-19 study

(Sharecast News) - Pharmaceutical services company Open Orphan has signed a contract with the UK Government that will see the firm assist in the development of a Covid-19 human challenge study model to safely speed up the development of an efficacious vaccine.

Read more
16 Oct 2020 15:24

IN BRIEF: Open Orphan In Talks With UK Government Over Corona Study

IN BRIEF: Open Orphan In Talks With UK Government Over Corona Study

Read more
16 Oct 2020 08:57

Open Orphan continues talks over coronavirus challenge study

(Sharecast News) - Open Orphan updated the market on its talks with the UK government and other partners for a coronavirus challenge study in the UK on Friday, confirming that "advanced negotiations" were ongoing.

Read more
30 Sep 2020 18:37

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

Read more
28 Sep 2020 19:34

IN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study Contract

IN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study Contract

Read more
24 Sep 2020 17:35

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

Read more
22 Sep 2020 19:35

IN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract Win

IN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract Win

Read more
22 Sep 2020 09:43

Open Orphan subsidiary wins 'important' new contract

(Sharecast News) - Pharmaceutical contract research organisation Open Orphan secured an "important" new contract to support an unnamed European client via its French subsidiary, Venn Life Sciences.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.